Clinical impact of functional CYP2C19 and CYP2D6 gene variants on treatment outcomes in patients with depression: a Danish cohort study

INTRODUCTION: Pharmacogenetic (PGx) targets to optimize drug therapy, but its implementation is rare. OBJECTIVES: We evaluate the clinical utility of PGx testing in psychiatry by investigating the one-year risks of clinical outcomes in patients with depression taking sertraline, (es)citalopram or fl...

Descripción completa

Detalles Bibliográficos
Autores principales: Thiele, L., Ishtiak-Ahmed, K., Thirstrup, J., Lunenburg, C., Müller, D., Gasse, C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2022
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9565563/
http://dx.doi.org/10.1192/j.eurpsy.2022.591

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9565563/
http://dx.doi.org/10.1192/j.eurpsy.2022.591

Ejemplares similares